The consequence of this translocation is the generation of the BCR-ABL1 fusion protein, endowed with constitutive kinase activity that is not only necessary, but also, importantly, sufficient for CML pathogenesis [1]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.